Overweight and obesity

7 total trials 1 recruiting

Filter these 7 trials by phase, country, sponsor and more.

Open in Search →

Effect on the tolerability of semaglutide in overweight adults without diabetes Pending

2025-524612-11-00 6
IDEAL-COR Recruiting

2023-505270-15-00 11 2024-08-19
Weight loss in people living with overweight or obesity following treatment with cagrilintide Recruitment ended

2024-519530-24-00 5 2025-10-31
Weight loss in people living with overweight or obesity and type 2 diabetes following treatment with cagrilintide Recruitment ended

2024-519531-41-00 5 2025-10-31
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine … Recruitment ended

2023-504215-32-00 9 2023-09-28
A research study to see how well CagriSema helps people with excess body weight lose weight Recruitment ended

2023-506929-11-00 5 2022-10-17
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Witho … Ended

2023-510470-13-00 4 2023-03-10

Showing 1–7 of 7 trials